University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Insulin detemir and basal insulin therapy.

Russell-Jones, DL (2007) Insulin detemir and basal insulin therapy. Endocrinol Metab Clin North Am, 36 Sup. pp. 7-13.

Full text not available from this repository.


With the introduction of insulin detemir (Levemir [Novo Nordisk A/S, Bagsvaerd, Denmark]), a long-acting basal insulin analog, it is an opportune moment to reevaluate the use of basal insulin therapy and consider current treatment strategies, including the use of insulin detemir. This review examines the need for effective treatment options for diabetes and the economic burden of this disease. The importance of achieving glycemic control targets and the role of basal insulin therapy are discussed. Finally, the use of insulin detemir is briefly reviewed with a look at its clinical pharmacology, its use in basal insulin therapy, and its cost-effectiveness.

Item Type: Article
Divisions : Surrey research (other units)
Authors :
Date : August 2007
Uncontrolled Keywords : Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin, Insulin Detemir, Insulin, Long-Acting
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:05
Last Modified : 24 Jan 2020 16:00

Actions (login required)

View Item View Item


Downloads per month over past year

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800